MELISSA FONER: Open Payments
NPI 1184091407 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 44 payments from 15 companies in 2025. Trend: 2023 $699 · 2024 $716 · 2025 $926
Food & beverage: $908Education: $18
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $258 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| ABBVIE INC. | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Neurocrine BioSciences, Inc. | 3 | $76 |
| HARMONY BIOSCIENCES LLC | 2 | $64 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Abbott Laboratories | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
Products named: REXULTI, AUSTEDO XR, FANAPT, INGREZZA, WAKIX, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, COBENFY.
Industry payments across TN — which companies pay providers there.
